Ensuring the Safety and Efficacy of Biologics
This year's Immunogenicity Stream focuses on the latest science, technologies and strategies to ensure the safety and efficacy of biologics, with a particular focus on novel modalities including cell & gene therapies, bispecifics, immunotherapies
and ADCs. Part One provides a practical, comprehensive introduction to immunogenicity via an interactive training seminar. Part Two examines immunogenicity assessment and management including: assay development and validation, clinical relevance,
drug and target interference, risk assessment and recent advances with predictive studies and tools.
Programs Include:
May 11-12
Introduction to Immunogenicity
May 12-13
Immunogenicity Assessment and Management
Recommended Short Course:
SC3: Developability of Bispecific Antibodies: Formats and Applications
Instructor: Nimish Gera, PhD, Head, Biologics, Mythic Therapeutics
Keynote Speaker:
Boris Gorovits, PhD, Vice President, In Vitro Pharmacology, Biomarker Discovery and Bioanalysis, Sana Biotechnology